SMMT FY 2024 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

SMMTSummit Therapeutics Inc.

$12B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$15M

Operating Income

$313,000

Net Income

-$221M

EPS (Diluted)

$-0.31

Cash Flow

Operating Cash Flow

-$142M

Free Cash Flow

-$142M

Stock-Based Comp.

$51M

Balance Sheet

Total Assets

$436M

Total Liabilities

$47M

Stockholders' Equity

$389M

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$15M	-$2M	-632.0%
Operating Income	$313,000	-$90M	+100.3%
Net Income	-$221M	-$615M	+64.0%